Image-guided non-invasive ultrasound liver ablation using histotripsy: Feasibility study in an invivo porcine model

Ultrasound in Medicine and Biology

Volumn 39, Issue 8, 2013, Pages 1398-1409

  Vlaisavljevich, Eli ^a   Kim, Yohan ^a   Allen, Steven ^a   Owens, Gabe ^a   Pelletier, Shawn ^a   Cain, Charles ^a   Ives, Kimberly ^a   Xu, Zhen ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cavitation; Histotripsy; Liver cancer; Non invasive tissue ablation; Therapeutic ultrasound

Indexed keywords

ABLATION; CAVITATION; DISEASES; ULTRASONICS;

ACOUSTIC CAVITATIONS; HEPATOCELLULAR CARCINOMA; HISTOTRIPSY; LIVER CANCERS; PULSE REPETITION FREQUENCIES; THERAPEUTIC ULTRASOUND; THERAPY TRANSDUCERS; TISSUE ABLATIONS;

TISSUE;

ABDOMEN; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; FEASIBILITY STUDY; FRACTIONATION; GALLBLADDER; HIGH INTENSITY FOCUSED ULTRASOUND; HISTOTRIPSY; IN VIVO STUDY; LIVER CELL CARCINOMA; LIVER PARENCHYMA; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SURGICAL TECHNIQUE; SWINE; THERMAL ANALYSIS; THORAX; ULTRASOUND TRANSDUCER; UNITED STATES;

EID: 84880041478     PISSN: 03015629     EISSN: 1879291X     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2013.02.005     Document Type: Article

References (61)

1. Arnold P., Preiswerk F., Fasel B., Salomir R., Scheffler K., Cattin P.C. 3 D organ motion prediction for MR-guided high intensity focused ultrasound. Med Image Comput Comput Assist Interv 2011, 14:623-630.
2. Aschoff A.J., Merkle E.M., Wong V., Zhang Q., Mendez M.M., Duerk J.L., Lewin J.S. How does alteration of hepatic blood flow affect liver perfusion and radiofrequency-induced thermal lesion size in rabbit liver?. JMagn Reson Imaging 2001, 13:57-63.
3. Bobkova S., Gavrilov L., Khokhlova V., Shaw A., Hand J. Focusing of high-intensity ultrasound through the rib cage using a therapeutic random phased array. Ultrasound Med Biol 2010, 36:888-906.
4. Bosch F.X., Ribes J., Diaz M., Cleries R. Primary liver cancer: Worldwide incidence and trends. Gastroenterology 2004, 127:S5-S16.
5. Charnley R.M., Doran J., Morris D.L. Cryotherapy for liver metastases: A new approach. Br J Surg 1989, 76:1040-1041.
6. Chen L., ter Haar G., Hill C.R., Dworkin M., Carnochan P., Young H., Bensted J.P. Effect of blood perfusion on the ablation of liver parenchyma with high-intensity focused ultrasound. Phys Med Biol 1993, 38:1661-1673.
7. Cho Y.K., Kim J.K., Kim M.Y., Rhim H., Han J.K. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 2009, 49:453-459.
8. Cochard E., Prada C., Aubry J.F., Fink M. Ultrasonic focusing through the ribs using the DORT method. Med Phys 2009, 36:3495-3503.
9. Curley S.A. Radiofrequency ablation of malignant liver tumors. Oncologist 2001, 6:14-23.
10. Davis C.R. Interventional radiological treatment of hepatocellular carcinoma. Cancer Control 2010, 17:87-99.
11. De Senneville B.D., Ries M., Maclair G., Moonen C. MR-guided thermotherapy of abdominal organs using a robust PCA-based motion descriptor. IEEE Trans Med Imaging 2011, 30:1987-1995.
12. El-Serag H.B., Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. NEngl J Med 1999, 340:745-750.
13. Erce C., Parks R.W. Interstitial ablative techniques for hepatic tumours. Br J Surg 2003, 90:272-289.
14. Fischer K., Gedroyc W., Jolesz F.A. Focused ultrasound as a local therapy for liver cancer. Cancer J 2010, 16:118-124.
15. Hall T.L., Lee G.R., Hernandez L., Cain C.A. Relaxation properties of cavitation induced tissue lesions. European Society for Magnetic Resonance in Medicine and Biology 2007, 1118.
16. Hall T.L., Hempel C.R., Wojno K., Xu Z., Cain C.A., Roberts W.W. Histotripsy of the prostate: Dose effects in a chronic canine model. Urology 2009, 74:932-937.
17. Head H.W., Dodd G.D. Thermal ablation for hepatocellular carcinoma. Gastroenterology 2004, 127:S167-S178.
18. Hein I.A., O'Brien W.R. Current time-domain methods for assessing tissue motion by analysis from reflected ultrasound echoes: A review. IEEE Trans Ultrason Ferroelectr Freq Control 1993, 40:84-102.
19. Hempel C.R., Hall T.L., Cain C.A., Fowlkes J.B., Xu Z., Roberts W.W. Histotripsy fractionation of prostate tissue: Local effects and systemic response in a canine model. JUrol 2011, 185:1484-1489.
20. Illing R.O., Kennedy J.E., Wu F., ter Haar G.R., Protheroe A.S., Friend P.J., Gleeson F.V., Cranston D.W., Phillips R.R., Middleton M.R. The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population. Br J Cancer 2005, 93:890-895.
21. Izumi N. Recent advances of radiofrequency ablation for early hepatocellular carcinoma. JGastroenterol Hepatol 2011, 26(Suppl 1):115-122.
22. Jain R.K. Determinants of tumor blood flow: A review. Cancer Res 1988, 48:2641-2658.
23. Jung S.E., Cho S.H., Jang J.H., Han J.Y. High-intensity focused ultrasound ablation in hepatic and pancreatic cancer: Complications. Abdom Imaging 2011, 36:185-195.
24. Khokhlova V.A., Bobkova S.M., Gavrilov L.R. Focus splitting associated with propagation of focused ultrasound through the rib cage. Acoust Phys 2010, 56:665-674.
25. Kim Y., Gelehrter S.K., Fifer C.G., Lu J.C., Owens G.E., Berman D.R., Williams J., Wilkinson J.E., Ives K.A., Xu Z. Non-invasive pulsed cavitational ultrasound for fetal tissue ablation: Feasibility study in a fetal sheep model. Ultrasound Obstet Gynecol 2011, 37:450-457.
26. Kim Y., Wang T.Y., Xu Z., Cain C.A. Lesion generation through ribs using histotripsy therapy without aberration correction. IEEE Trans Ultrason Ferroelectr Freq Control 2011, 58:2334-2343.
27. Kudo M. Radiofrequency ablation for hepatocellular carcinoma: Updated review in 2010. Oncology 2010, 78(Suppl 1):113-124.
28. Lake A.M., Hall T.L., Kieran K., Fowlkes J.B., Cain C.A., Roberts W.W. Histotripsy: Minimally invasive technology for prostatic tissue ablation in an invivo canine model. Urology 2008, 72:682-686.
29. Leslie T.A., Kennedy J.E. High-intensity focused ultrasound principles, current uses, and potential for the future. Ultrasound Q 2006, 22:263-272.
30. Leslie T.A., Kennedy J.E., Illing R.O., Ter Haar G.R., Wu F., Phillips R.R., Friend P.J., Roberts I.S., Cranston D.W., Middleton M.R. High-intensity focused ultrasound ablation of liver tumours: Can radiological assessment predict the histological response?. Br J Radiol 2008, 81:564-571.
31. Li C.X., Xu G.L., Li J.J., Luo G.Y. [High intensity focused ultrasound for liver cancer]. Zhonghua Zhong Liu Za Zhi 2003, 25:94-96.
32. Liapi E., Geschwind J.F. Transcatheter and ablative therapeutic approaches for solid malignancies. JClin Oncol 2007, 25:978-986.
33. Livraghi T., Makisalo H., Line P.D. Treatment options in hepatocellular carcinoma today. Scand J Surg 2011, 100:22-29.
34. Livraghi T., Solbiati L., Meloni M.F., Gazelle G.S., Halpern E.F., Goldberg S.N. Treatment of focal liver tumors with percutaneous radio-frequency ablation: Complications encountered in a multicenter study. Radiology 2003, 226:441-451.
35. Lu D.S., Raman S.S., Limanond P., Aziz D., Economou J., Busuttil R., Sayre J. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. JVasc Interv Radiol 2003, 14:1267-1274.
36. Marquet F., Aubry J.F., Pernot M., Fink M., Tanter M. Optimal transcostal high-intensity focused ultrasound with combined real-time 3 D movement tracking and correction. Phys Med Biol 2011, 56:7061-7080.
37. Marrero J.A., Pelletier S. Hepatocellular carcinoma. Clin Liver Dis 2006, 10:339-351. ix.
38. Maxwell A.D., Owens G., Gurm H.S., Ives K., Myers D.D., Xu Z. Noninvasive treatment of deep venous thrombosis using pulsed ultrasound cavitation therapy (histotripsy) in a porcine model. JVasc Interv Radiol 2011, 22:369-377.
39. McWilliams J.P., Yamamoto S., Raman S.S., Loh C.T., Lee E.W., Liu D.M., Kee S.T. Percutaneous ablation of hepatocellular carcinoma: Current status. JVasc Interv Radiol 2010, 21:S204-S213.
40. Miller RM, Kim Y, Lin K, Owens G, Cain CA, Xu Z. Real-time motion tracking for non-invasive ultrasound cardiac therapy. IEEE International Ultrasonics Symposium, 2011.
41. Okada A., Murakami T., Mikami K., Onishi H., Tanigawa N., Marukawa T., Nakamura H. Acase of hepatocellular carcinoma treated by MR-guided focused ultrasound ablation with respiratory gating. Magn Reson Med Sci 2006, 5:167-171.
42. Owens G.E., Miller R.M., Ensing G., Ives K., Gordon D., Ludomirsky A., Xu Z. Therapeutic ultrasound to noninvasively create intracardiac communications in an intact animal model. Catheter Cardiovasc Interv 2011, 77:580-588.
43. Parikh S., Hyman D. Hepatocellular cancer: A guide for the internist. Am J Med 2007, 120:194-202.
44. Park M.Y., Jung S.E., Cho S.H., Piao X.H., Hahn S.T., Han J.Y., Woo I.S. Preliminary experience using high intensity focused ultrasound for treating liver metastasis from colon and stomach cancer. Int J Hyperthermia 2009, 25:180-188.
45. Parsons J.E., Cain C.A., Abrams G.D., Fowlkes J.B. Pulsed cavitational ultrasound therapy for controlled tissue homogenization. Ultrasound Med Biol 2006, 32:115-129.
46. Parsons J.E., Cain C.A., Fowlkes J.B. Cost-effective assembly of a basic fiber-optic hydrophone for measurement of high-amplitude therapeutic ultrasound fields. JAcoust Soc Am 2006, 119:1432-1440.
47. Patterson E.J., Scudamore C.H., Owen D.A., Nagy A.G., Buczkowski A.K. Radiofrequency ablation of porcine liver invivo: Effects of blood flow and treatment time on lesion size. Ann Surg 1998, 227:559-565.
48. Pelletier S.J., Fu S., Thyagarajan V., Romero-Marrero C., Batheja M.J., Punch J.D., Magee J.C., Lok A.S., Fontana R.J., Marrero J.A. An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data. Liver Transpl 2009, 15:859-868.
49. Pernot M., Tanter M., Fink M. 3-D real-time motion correction in high-intensity focused ultrasound therapy. Ultrasound Med Biol 2004, 30:1239-1249.
50. Ries M., de Senneville B.D., Roujol S., Berber Y., Quesson B., Moonen C. Real-time 3 D target tracking in MRI guided focused ultrasound ablations in moving tissues. Magn Reson Med 2010, 64:1704-1712.
51. Roberts W.W., Hall T.L., Ives K., Wolf J.S., Fowlkes J.B., Cain C.A. Pulsed cavitational ultrasound: A noninvasive technology for controlled tissue ablation (histotripsy) in the rabbit kidney. JUrol 2006, 175:734-738.
52. Styn N.R., Wheat J.C., Hall T.L., Roberts W.W. Histotripsy of VX-2 tumor implanted in a renal rabbit model. JEndourol 2010, 24:1145-1150.
53. Ter Haar G. High intensity ultrasound. Semin Laparosc Surg 2001, 8:77-89.
54. Vlaisavljevich E, Cain CA, Xu Z. Effects of tissue mechanical properties on histotripsy. IEEE International Ultrasonics Symposium, 2011.
55. Wang H., Ebbini E.S., Odonnell M., Cain C.A. Phase aberration correction and motion compensation for ultrasonic hyperthermia phased-arrays: Experimental results. IEEE Trans Ultrason Ferr 1994, 41:34-43.
56. Wang T.Y., Hall T.L., Xu Z., Fowlkes J.B., Cain C.A. Imaging feedback of histotripsy treatments using ultrasound shear wave elastography. IEEE Trans Ultrason Ferroelectr Freq Control 2012, 59:1167-1181.
57. Wang T.Y., Xu Z., Winterroth F., Hall T.L., Fowlkes J.B., Rothman E.D., Roberts W.W., Cain C.A. Quantitative ultrasound backscatter for pulsed cavitational ultrasound therapy: Histotripsy. IEEE Trans Ultrason Ferroelectr Freq Control 2009, 56:995-1005.
58. Wu F., Wang Z.B., Chen W.Z., Wang W., Gui Y., Zhang M., Zheng G., Zhou Y., Xu G., Li M., Zhang C., Ye H., Feng R. Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China: An overview. Ultrason Sonochem 2004, 11:149-154.
59. Xu Z., Ludomirsky A., Eun L.Y., Hall T.L., Tran B.C., Fowlkes J.B., Cain C.A. Controlled ultrasound tissue erosion. IEEE Trans Ultrason Ferroelectr Freq Control 2004, 51:726-736.
60. Xu Z., Owens G., Gordon D., Cain C., Ludomirsky A. Noninvasive creation of an atrial septal defect by histotripsy in a canine model. Circulation 2010, 121:742-749.
61. Zhang L., Zhu H., Jin C., Zhou K., Li K., Su H., Chen W., Bai J., Wang Z. High-intensity focused ultrasound (HIFU): Effective and safe therapy for hepatocellular carcinoma adjacent to major hepatic veins. Eur Radiol 2009, 19:437-445.